» Articles » PMID: 37443832

SHIP1 Is Present but Strongly Downregulated in T-ALL, and After Restoration Suppresses Leukemia Growth in a T-ALL Xenotransplantation Mouse Model

Overview
Journal Cells
Publisher MDPI
Date 2023 Jul 14
PMID 37443832
Authors
Affiliations
Soon will be listed here.
Abstract

Acute lymphoblastic leukemia (ALL) is the most common cause of cancer-related death in children. Despite significantly increased chances of cure, especially for high-risk ALL patients, it still represents a poor prognosis for a substantial fraction of patients. Misregulated proteins in central switching points of the cellular signaling pathways represent potentially important therapeutic targets. Recently, the inositol phosphatase SHIP1 (SH2-containing inositol 5-phosphatase) has been considered as a tumor suppressor in leukemia. SHIP1 serves as an important negative regulator of the PI3K/AKT signaling pathway, which is frequently constitutively activated in primary T-ALL. In contrast to other reports, we show for the first time that SHIP1 has not been lost in T-ALL cells, but is strongly downregulated. Reduced expression of SHIP1 leads to an increased activation of the PI3K/AKT signaling pathway. SHIP1-mRNA expression is frequently reduced in primary T-ALL samples, which is recapitulated by the decrease in SHIP1 expression at the protein level in seven out of eight available T-ALL patient samples. In addition, we investigated the change in the activity profile of tyrosine and serine/threonine kinases after the restoration of SHIP1 expression in Jurkat T-ALL cells. The tyrosine kinase receptor subfamilies of NTRK and PDGFR, which are upregulated in T-ALL subgroups with low SHIP1 expression, are significantly disabled after SHIP1 reconstitution. Lentiviral-mediated reconstitution of SHIP1 expression in Jurkat cells points to a decreased cellular proliferation upon transplantation into NSG mice in comparison to the control cohort. Together, our findings will help to elucidate the complex network of cell signaling proteins, further support a functional role for SHIP1 as tumor suppressor in T-ALL and, much more importantly, show that full-length SHIP1 is expressed in T-ALL samples.

Citing Articles

Selective Aurora A-TPX2 Interaction Inhibitors Have Efficacy as Targeted Antimitotic Agents.

Stockwell S, Scott D, Fischer G, Guarino E, Rooney T, Feng T J Med Chem. 2024; 67(17):15521-15536.

PMID: 39190548 PMC: 11403621. DOI: 10.1021/acs.jmedchem.4c01165.


Ikaros sets the threshold for negative B-cell selection by regulation of the signaling strength of the AKT pathway.

Ehm P, Horn S, Hoffer K, Kriegs M, Horn M, Giehler S Cell Commun Signal. 2024; 22(1):360.

PMID: 38992657 PMC: 11241878. DOI: 10.1186/s12964-024-01732-5.


The Functional Roles of the Src Homology 2 Domain-Containing Inositol 5-Phosphatases SHIP1 and SHIP2 in the Pathogenesis of Human Diseases.

Muller S, Jucker M Int J Mol Sci. 2024; 25(10).

PMID: 38791291 PMC: 11121230. DOI: 10.3390/ijms25105254.

References
1.
Mansour M, Sanda T, Lawton L, Li X, Kreslavsky T, Novina C . The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia. J Exp Med. 2013; 210(8):1545-57. PMC: 3727321. DOI: 10.1084/jem.20122516. View

2.
Espinosa L, Cathelin S, DAltri T, Trimarchi T, Statnikov A, Guiu J . The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia. Cancer Cell. 2010; 18(3):268-81. PMC: 2963042. DOI: 10.1016/j.ccr.2010.08.006. View

3.
Jotta P, Ganazza M, Silva A, Viana M, da Silva M, Zambaldi L . Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia. Leukemia. 2009; 24(1):239-42. DOI: 10.1038/leu.2009.209. View

4.
Liberzon A, Birger C, Thorvaldsdottir H, Ghandi M, Mesirov J, Tamayo P . The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2016; 1(6):417-425. PMC: 4707969. DOI: 10.1016/j.cels.2015.12.004. View

5.
Hamilton M, Ho V, Kuroda E, Ruschmann J, Antignano F, Lam V . Role of SHIP in cancer. Exp Hematol. 2010; 39(1):2-13. DOI: 10.1016/j.exphem.2010.11.002. View